Cure My Disease

Don't miss your cure!

 Log in / Sign up

Remote leg strength test could change PAD monitoring

NCT ID NCT07497360

Recruiting now Knowledge-focused Sponsor: Izmir Democracy University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a simple leg strength test, the 30-second sit-to-stand test, gives the same results when done over a video call as in person. Researchers will enroll 45 adults with peripheral artery disease (PAD) to compare both methods. If remote testing proves reliable, it could make follow-up care easier for patients who have trouble traveling to clinics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could show that remote assessments are reliable for monitoring leg strength in PAD patients, making follow-up care more convenient.
What could go wrong
This is a small, early-stage study with only 45 participants, so results may not apply to all PAD patients. The study does not test a treatment, only a measurement method.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL ARTERIAL DISEASE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dokuz Eylul University Faculty of Medicine

    RECRUITING

    Izmir, Balçova, 35330, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.